82 related articles for article (PubMed ID: 10646814)
1. Addition of gonadotrophin-releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles.
Karlström PO; Bergh T; Lundkvist O
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):37-42. PubMed ID: 10646814
[TBL] [Abstract][Full Text] [Related]
2. Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial.
Eskandar MA
Gynecol Endocrinol; 2007 Oct; 23(10):551-5. PubMed ID: 17891598
[TBL] [Abstract][Full Text] [Related]
3. [Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
Zhao X; Zhang L; Gong S
Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):589-92. PubMed ID: 9642373
[TBL] [Abstract][Full Text] [Related]
4. One versus two inseminations per cycle in intrauterine insemination with sperm from patients' husbands: a systematic review of the literature.
Osuna C; Matorras R; Pijoan JI; Rodríguez-Escudero FJ
Fertil Steril; 2004 Jul; 82(1):17-24. PubMed ID: 15236980
[TBL] [Abstract][Full Text] [Related]
5. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
[TBL] [Abstract][Full Text] [Related]
6. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
[TBL] [Abstract][Full Text] [Related]
7. Superovulation with buserelin and gonadotropins dramatically improves the success rate of intrauterine insemination with husband's washed semen.
Allegra A; Volpes A; Coffaro F; Guida S; Francofonte R
Acta Eur Fertil; 1990; 21(4):191-5. PubMed ID: 2128158
[TBL] [Abstract][Full Text] [Related]
8. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
11. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
12. Superovulation with or without intrauterine insemination for the treatment of infertility.
Hurst BS; Tjaden BL; Kimball A; Schlaff WD; Damewood MD; Rock JA
J Reprod Med; 1992 Mar; 37(3):237-41. PubMed ID: 1564710
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
Demirol A; Gurgan T
Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
[TBL] [Abstract][Full Text] [Related]
16. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
Erdem A; Erdem M; Atmaca S; Guler I
Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
[TBL] [Abstract][Full Text] [Related]
17. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
Andersen AN; Devroey P; Arce JC
Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
20. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]